EMEA-000851-PIP01-10 - paediatric investigation plan

Pollen from Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense, Poa pratensis, Secale cereale and Artemisia vulgaris
PIPHuman

Key facts

Active Substance
Pollen from Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense, Poa pratensis, Secale cereale and Artemisia vulgaris
Therapeutic area
Pneumology-allergology
Decision number
P/298/2010
PIP number
EMEA-000851-PIP01-10
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
  • Treatment of rhino-conjuctivitis
  • Treatment of allergic rhinitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries

ALK-Abelló A/S

lcndk@alk-abello.com
ALKMRPdk@alk-abello.com
Denmark
Phone: +45 45748037
Fax: +45 45748600

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date

Decision

Share this page